Checkpoint stockholders will also receive a contingent value right for up to $0.70 per share on achievement of certain milestone Checkpoint stockholders will also receive a contingent value right for up to $0.70 per share on achievement of certain milestone Industry Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million
